A clinical and economic assessment of adjuvanted trivalent versus standard egg-derived quadrivalent influenza vaccines among older adults in the United States …
MJ Levin, V Divino, MJ Postma, SI Pelton… - Expert review of …, 2024 - Taylor & Francis
Background Clinical evidence supports use of enhanced influenza vaccines in older adults.
Few economic outcome studies have compared adjuvanted trivalent inactivated (aIIV3) and …
Few economic outcome studies have compared adjuvanted trivalent inactivated (aIIV3) and …
[HTML][HTML] Evaluating the relative vaccine effectiveness of adjuvanted trivalent influenza vaccine compared to high-dose trivalent and other egg-based influenza …
SI Pelton, V Divino, D Shah, J Mould-Quevedo… - Vaccines, 2020 - mdpi.com
The influenza-related disease burden is highest among the elderly. We evaluated the
relative vaccine effectiveness (rVE) of adjuvanted trivalent influenza vaccine (aTIV) …
relative vaccine effectiveness (rVE) of adjuvanted trivalent influenza vaccine (aTIV) …
[HTML][HTML] Comparing the clinical and economic outcomes associated with adjuvanted versus high-dose trivalent influenza vaccine among adults aged≥ 65 years in the …
MJ Levin, V Divino, D Shah, M DeKoven… - Vaccines, 2021 - mdpi.com
The burden of influenza is disproportionally higher among older adults. We evaluated the
relative vaccine effectiveness (rVE) of adjuvanted trivalent (aIIV3) compared to high-dose …
relative vaccine effectiveness (rVE) of adjuvanted trivalent (aIIV3) compared to high-dose …
[HTML][HTML] A retrospective cohort study assessing relative effectiveness of adjuvanted versus high-dose trivalent influenza vaccines among older adults in the United …
SI Pelton, V Divino, MJ Postma, D Shah… - Vaccine, 2021 - Elsevier
Purpose To evaluate the relative vaccine effectiveness (rVE) against influenza-related
hospitalizations/emergency room (ER) visits, influenza-related office visits, and cardio …
hospitalizations/emergency room (ER) visits, influenza-related office visits, and cardio …
[HTML][HTML] Relative vaccine effectiveness of adjuvanted trivalent influenza vaccine over three consecutive influenza seasons in the United States
C Boikos, I McGovern, JR Ortiz, J Puig-Barberà… - Vaccines, 2022 - mdpi.com
Traditional influenza vaccines may be less immunogenic in adults≥ 65 years of age due to
immunosenescence. Two influenza vaccines—MF59®-adjuvanted trivalent inactivated …
immunosenescence. Two influenza vaccines—MF59®-adjuvanted trivalent inactivated …
[PDF][PDF] Relative Vaccine Effective-ness of Adjuvanted Trivalent Influ-enza Vaccine over Three Consecu-tive Influenza Seasons in the United States. Vaccines 2022, 10 …
C Boikos, I McGovern, JR Ortiz, JP Barberà, E Versage… - 2022 - researchgate.net
Traditional influenza vaccines may be less immunogenic in adults≥ 65 years of age due to
immunosenescence. Two influenza vaccines—MF59®-adjuvanted trivalent inactivated …
immunosenescence. Two influenza vaccines—MF59®-adjuvanted trivalent inactivated …
29. Impact of Enhanced Influenza Vaccines on Direct Healthcare Costs for the US Elderly: A Comprehensive Real-World Evaluation of Adjuvanted Trivalent Influenza …
M Postma, SI Pelton, V Divino… - Open Forum …, 2020 - ncbi.nlm.nih.gov
Background Influenza generates a substantial economic burden ($3.2 B in the US annually)
due to direct medical costs such as physician office visits or hospitalizations, especially …
due to direct medical costs such as physician office visits or hospitalizations, especially …
Safety, reactogenicity, and health-related quality of life after trivalent adjuvanted vs trivalent high-dose inactivated influenza vaccines in older adults: a randomized …
KE Schmader, CK Liu, T Harrington… - JAMA Network …, 2021 - jamanetwork.com
Importance Trivalent adjuvanted inactivated influenza vaccine (aIIV3) and trivalent high-
dose inactivated influenza vaccine (HD-IIV3) are US-licensed for adults aged 65 years and …
dose inactivated influenza vaccine (HD-IIV3) are US-licensed for adults aged 65 years and …
Relative effectiveness of high dose versus standard dose influenza vaccines in older adult outpatients over four seasons, 2015–16 to 2018–19
GK Balasubramani, WS Choi, MP Nowalk… - Vaccine, 2020 - Elsevier
Background New influenza vaccine formulations are designed to improve vaccine
effectiveness and protect those most vulnerable to infection. High dose trivalent inactivated …
effectiveness and protect those most vulnerable to infection. High dose trivalent inactivated …
[HTML][HTML] Relative effectiveness of adjuvanted versus non-adjuvanted influenza vaccines in older adults with risk factors for influenza complications during the 2019 …
M Imran, C Mills, KW McDermott, A Dean, A Bogdanov… - Vaccine, 2024 - Elsevier
This study estimated the relative vaccine effectiveness (rVE) of the MF59®-adjuvanted
trivalent influenza vaccine (aTIV) versus standard-dose nonadjuvanted egg-based …
trivalent influenza vaccine (aTIV) versus standard-dose nonadjuvanted egg-based …